Very high real-world efficacy of ritonavir boosted paritaprevir with ombitasvir and dasabuvir plus /- ribavirin in hepatitis C genotype 1 in patients with advanced fibrosis -Final results of the REV1TAL study

REV1TAL Working Grp

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

43 Citations (Scopus)
Original languageEnglish
Pages (from-to)521-527
Number of pages7
JournalJournal of Hepatology
Issue number3
Publication statusPublished - 1 Mar 2017
EventInternational Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver - Amsterdam, Netherlands
Duration: 19 Apr 201723 Apr 2017

Cite this